Dynamic cardiomyoplasty at seven years

Carpentier, A; Chachques, Juan-Carlos; Acar, Christophe; Relland, J.; Mihǎileanu, Serban; Bensasson, D; Kieffer, J.P.; Guibourt, P; Tournay, D; Roussin, Isabelle

doi:10.1016/s0022-5223(19)33739-0

Cited by 177 publications

(55 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Dynamic cardiomyoplasty is a surgical technique in which the patient' s own latissimus dorsi muscle is wrapped around the heart and stimulated by a pacemaker. 101 Cardiomyoplasty eliminates the need for a donor organ and immunosuppression. The procedure has been performed since 1985 in over 600 patients worldwide.…”

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

“…The procedure has been performed since 1985 in over 600 patients worldwide. 101 Improvement in symptoms and indexes of left ventricular performance were reported in patients with both ischemic cardiomyopathy and idiopathic dilated cardiomyopathy, although survival does not appear to be improved. 102 First-year survival after cardiomyoplasty is 75-80% but decreases consistently in the next 2-3 years.…”

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

“…103 Cardiomyoplasty cannot be considered a replacement for transplantation, as many patients undergoing the procedure underwent subsequent transplantation. 101 Its role is considered investigational and will be determined by results of randomized, prospective trials. 101 Left Ventricular Volume-Reduction Surgery Ventricular volume reduction or remodeling has received extensive media publicity.…”

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

“…101 Its role is considered investigational and will be determined by results of randomized, prospective trials. 101 Left Ventricular Volume-Reduction Surgery Ventricular volume reduction or remodeling has received extensive media publicity. 104 A portion of the dilated left ventricle is removed, with repair of the mitral and tricuspid valves.…”

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

See 3 more Smart Citations

Advances in the Treatment of Congestive Heart Failure: New Approaches for an Old Disease

et al. 2000

View full text Add to dashboard Cite

Heart failure is a symptom complex of varied etiology associated with substantial mortality. Approximately 5 million Americans have the disease, with 400,000 new cases diagnosed each year. Despite better understanding of its pathophysiology, therapeutic options remain suboptimal and the syndrome remains associated with high rates of hospitalization and loss of economic productivity. Management traditionally included vasodilators, diuretics, and digoxin, with a focus on controlling symptoms and improving ejection fraction and exercise capacity. Drug therapy now is focused on improving survival, with a reduction in health care costs related to hospitalizations. Drugs with a proven benefit in reducing morbidity and mortality are angiotensin-converting enzyme inhibitors, beta-blockers, and the combination of hydralazine plus a nitrate. Diuretics, digoxin, dihydropyridine calcium channel blockers, phosphodiesterase inhibitors, catecholamine infusions, amiodarone, left ventricular assist devices, and transplantation are also options.

show abstract

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

Section: Dynamic Cardiomyoplastymentioning

confidence: 99%

See 2 more Smart Citations

Advances in the Treatment of Congestive Heart Failure: New Approaches for an Old Disease

et al. 2000

View full text Add to dashboard Cite

show abstract

“…In the attempt to benefit a large number of patients, other surgical procedures have been suggested such as cardiomyoplasty, [4][5][6][7] partial left ventriculectomy, [8][9][10][11] mitral valve correction, [12][13][14][15][16] biventricular pacing, 17,18 and myocardial revascularization itself. 19 Mitral insufficiency is one of the factors causing severe hemodynamic changes in end-stage dilated cardiomyopathy.…”

Section: Introductionmentioning

confidence: 99%

End-Stage Cardiomyopathy and Secondary Mitral Insufficiency Surgical Alternative with Prosthesis Implant and Left Ventricular Remodeling

Buffolo¹,

Paula²,

Aguiar³

et al. 2003

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Secondary mitral insufficiency is a strong risk factor for death in end-stage cardiomyopathies. The possible correction of mitral regurgitation is now being accepted as an alternative to cardiac transplantation in a special subset of patients. We proposed a new surgical approach that consisted of implantation of a mitral prosthesis smaller than the annulus, as well as preservation and traction of the papillary muscles to reduce sphericity of the left ventricle. Between December 1995 and August 2001, 71 cases were operated on including the following etiologies: ischemic (38), idiopathic (29), Chaga's disease (2), viral (1), and postpartum (1). All patients were in an end-stage phase with more than two hospital admissions in the last three months; seven were in intensive care units receiving drugs and intra-aortic balloon counterpulsation, and one was in cardiogenic shock. The patients were analyzed according to clinical criteria, echocardiographic findings, and morphology of the left ventricle. Hospital mortality was 16.9% (12/71) and mid-term follow-up showed evidence of improvement in clinical status and some echocardiographic parameters. This technique, despite a high mortality rate (due to other clinical conditions at the time of surgery), offers a promising therapeutic alternative for the treatment of patients in refractory heart failure with cardiomyopathy associated with secondary mitral regurgitation.

show abstract

References

2003

The Natural and Modifed History of Congenital Heart Disease

View full text Add to dashboard Cite

Dynamic cardiomyoplasty at seven years

Cited by 177 publications

References 10 publications

Advances in the Treatment of Congestive Heart Failure: New Approaches for an Old Disease

Advances in the Treatment of Congestive Heart Failure: New Approaches for an Old Disease

End-Stage Cardiomyopathy and Secondary Mitral Insufficiency Surgical Alternative with Prosthesis Implant and Left Ventricular Remodeling

References

Contact Info

Product

Resources

About